|
G
|
Cat
|
catalase
|
decreases activity multiple interactions
|
EXP
|
flubendiamide results in decreased activity of CAT protein alpha-Tocopherol affects the reaction [flubendiamide results in decreased activity of CAT protein]
|
CTD |
PMID:27823922 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
G
|
Ryr1
|
ryanodine receptor 1
|
multiple interactions
|
ISO
|
flubendiamide promotes the reaction [Ryanodine binds to RYR1 protein]
|
CTD |
PMID:30329129 |
|
NCBI chr 1:93,420,078...93,551,305
Ensembl chr 1:93,420,078...93,551,305
|
|
|
G
|
Agt
|
angiotensinogen
|
increases expression multiple interactions
|
EXP
|
Iohexol results in increased expression of AGT protein telmisartan inhibits the reaction [Iohexol results in increased expression of AGT protein]
|
CTD |
PMID:19452295 |
|
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
|
|
G
|
Bak1
|
BCL2-antagonist/killer 1
|
increases expression
|
ISO
|
Iohexol results in increased expression of BAK1 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,102,335...5,110,974
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases expression multiple interactions
|
ISO EXP
|
Iohexol results in increased expression of BAX mRNA; Iohexol results in increased expression of BAX protein Amlodipine inhibits the reaction [Iohexol results in increased expression of BAX protein]; cilnidipine inhibits the reaction [Iohexol results in increased expression of BAX protein]; Nifedipine inhibits the reaction [Iohexol results in increased expression of BAX protein]
|
CTD |
PMID:29705293 PMID:36207783 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
G
|
Bbc3
|
Bcl-2 binding component 3
|
increases expression
|
ISO
|
Iohexol results in increased expression of BBC3 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:86,141,603...86,150,666
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression multiple interactions
|
ISO EXP
|
Iohexol results in decreased expression of BCL2 protein Amlodipine inhibits the reaction [Iohexol results in decreased expression of BCL2 protein]; cilnidipine inhibits the reaction [Iohexol results in decreased expression of BCL2 protein]; Nifedipine inhibits the reaction [Iohexol results in decreased expression of BCL2 protein]
|
CTD |
PMID:36207783 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
G
|
Becn1
|
beclin 1
|
multiple interactions
|
ISO
|
[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of BECN1 protein; Berberine promotes the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of BECN1 protein]
|
CTD |
PMID:38705399 |
|
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
G
|
Bnip3
|
BCL2 interacting protein 3
|
multiple interactions
|
ISO
|
[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of BNIP3 protein; Berberine promotes the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of BNIP3 protein]
|
CTD |
PMID:38705399 |
|
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
|
|
G
|
Camk2g
|
calcium/calmodulin-dependent protein kinase II gamma
|
multiple interactions
|
ISO
|
CAMK2G protein inhibits the reaction [Iohexol results in increased expression of PPIF protein]; CAMK2G protein promotes the reaction [Iohexol results in increased cleavage of CASP3 protein]; cilnidipine inhibits the reaction [CAMK2G protein promotes the reaction [Iohexol results in increased cleavage of CASP3 protein]]
|
CTD |
PMID:36207783 |
|
NCBI chr15:3,504,017...3,563,050
Ensembl chr15:3,553,294...3,612,310
|
|
G
|
Casp1
|
caspase 1
|
multiple interactions
|
ISO
|
[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of and results in increased cleavage of CASP1 protein; [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CASP1 mRNA; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of and results in increased cleavage of CASP1 protein]; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CASP1 mRNA]
|
CTD |
PMID:38705399 |
|
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275
|
|
G
|
Casp3
|
caspase 3
|
multiple interactions increases cleavage increases activity
|
EXP ISO
|
Amlodipine inhibits the reaction [Iohexol results in increased cleavage of CASP3 protein]; Carnitine inhibits the reaction [Iohexol promotes the reaction [Glycerol results in increased expression of CASP3 mRNA]]; cilnidipine inhibits the reaction [Iohexol results in increased cleavage of CASP3 protein]; Iohexol promotes the reaction [Glycerol results in increased expression of CASP3 mRNA]; Nifedipine inhibits the reaction [Iohexol results in increased cleavage of CASP3 protein]; Telmisartan inhibits the reaction [Iohexol results in increased activity of CASP3 protein] Amlodipine inhibits the reaction [Iohexol results in increased cleavage of CASP3 protein]; CAMK2G protein promotes the reaction [Iohexol results in increased cleavage of CASP3 protein]; cilnidipine inhibits the reaction [CAMK2G protein promotes the reaction [Iohexol results in increased cleavage of CASP3 protein]]; cilnidipine inhibits the reaction [Iohexol results in increased cleavage of CASP3 protein]; Nifedipine inhibits the reaction [Iohexol results in increased cleavage of CASP3 protein]
|
CTD |
PMID:19452295 PMID:26562095 PMID:36207783 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp9
|
caspase 9
|
increases expression
|
ISO
|
Iohexol results in increased expression of CASP9 mRNA; Iohexol results in increased expression of CASP9 protein
|
CTD |
PMID:29705293 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
G
|
Ccl2
|
C-C motif chemokine ligand 2
|
increases expression multiple interactions
|
ISO
|
Iohexol results in increased expression of CCL2 protein [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CCL2 mRNA; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CCL2 mRNA]
|
CTD |
PMID:34774977 PMID:38705399 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
G
|
Cst3
|
cystatin C
|
multiple interactions
|
ISO
|
[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CST3 protein; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CST3 protein]
|
CTD |
PMID:38705399 |
|
NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:156,790,079...156,793,937
|
|
G
|
Eng
|
endoglin
|
decreases expression
|
ISO
|
Iohexol results in decreased expression of ENG protein
|
CTD |
PMID:29705293 |
|
NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:36,326,202...36,370,933
|
|
G
|
Fabp3
|
fatty acid binding protein 3
|
increases expression
|
ISO
|
Iohexol results in increased expression of FABP3 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:147,936,119...147,942,881
|
|
G
|
Gclm
|
glutamate cysteine ligase, modifier subunit
|
multiple interactions
|
EXP
|
[Drinking Water deficiency co-treated with Furosemide co-treated with Iohexol] results in decreased expression of GCLM mRNA
|
CTD |
PMID:29860548 |
|
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003
|
|
G
|
Havcr1
|
hepatitis A virus cellular receptor 1
|
increases expression multiple interactions
|
EXP
|
Iohexol results in increased expression of HAVCR1 protein Amlodipine inhibits the reaction [Iohexol results in increased expression of HAVCR1 protein]; cilnidipine inhibits the reaction [Iohexol results in increased expression of HAVCR1 protein]; Nifedipine inhibits the reaction [Iohexol results in increased expression of HAVCR1 protein]
|
CTD |
PMID:36207783 |
|
NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268
|
|
G
|
Hexb
|
hexosaminidase subunit beta
|
increases secretion
|
ISO
|
Iohexol results in increased secretion of HEXB protein
|
CTD |
PMID:34774977 |
|
NCBI chr 2:30,218,608...30,238,771
Ensembl chr 2:30,218,608...30,238,771
|
|
G
|
Hmgb1
|
high mobility group box 1
|
multiple interactions
|
EXP ISO
|
[Drinking Water deficiency co-treated with Furosemide co-treated with Iohexol] results in increased expression of HMGB1 protein [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of HMGB1 protein; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of HMGB1 protein]
|
CTD |
PMID:29860548 PMID:38705399 |
|
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
|
|
G
|
Hmox1
|
heme oxygenase 1
|
increases expression multiple interactions
|
ISO EXP
|
Iohexol results in increased expression of HMOX1 mRNA [Drinking Water deficiency co-treated with Furosemide co-treated with Iohexol] results in increased expression of HMOX1 mRNA
|
CTD |
PMID:29705293 PMID:29860548 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
G
|
Ifi44
|
interferon-induced protein 44
|
decreases expression
|
ISO
|
Iohexol results in decreased expression of IFI44 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 2:243,286,050...243,303,869
Ensembl chr 2:243,286,052...243,306,877
|
|
G
|
Ifih1
|
interferon induced with helicase C domain 1
|
decreases expression
|
ISO
|
Iohexol results in decreased expression of IFIH1 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 3:67,635,924...67,683,968
Ensembl chr 3:67,637,545...67,683,968
|
|
G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
EXP ISO
|
Carnitine inhibits the reaction [Iohexol promotes the reaction [Glycerol results in increased expression of IL1B mRNA]]; Iohexol promotes the reaction [Glycerol results in increased expression of IL1B mRNA] [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL1B mRNA; [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL1B protein; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL1B mRNA]; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL1B protein]
|
CTD |
PMID:26562095 PMID:38705399 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
G
|
Il6
|
interleukin 6
|
multiple interactions
|
ISO
|
[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL6 mRNA; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL6 mRNA]
|
CTD |
PMID:38705399 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
G
|
Lcn2
|
lipocalin 2
|
multiple interactions increases expression
|
EXP
|
Amlodipine inhibits the reaction [Iohexol results in increased expression of LCN2 protein]; cilnidipine inhibits the reaction [Iohexol results in increased expression of LCN2 protein]; Nifedipine inhibits the reaction [Iohexol results in increased expression of LCN2 protein]
|
CTD |
PMID:36207783 |
|
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842
|
|
G
|
Map3k1
|
mitogen-activated protein kinase kinase kinase 1
|
increases expression
|
ISO
|
Iohexol results in increased expression of MAP3K1 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:45,081,889...45,149,897
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
decreases phosphorylation
|
ISO
|
Iohexol results in decreased phosphorylation of MAPK1 protein
|
CTD |
PMID:34774977 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
G
|
Mapk14
|
mitogen activated protein kinase 14
|
increases expression
|
ISO
|
Iohexol results in increased expression of MAPK14 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
decreases phosphorylation
|
ISO
|
Iohexol results in decreased phosphorylation of MAPK3 protein
|
CTD |
PMID:34774977 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
G
|
Nlrp3
|
NLR family, pyrin domain containing 3
|
multiple interactions
|
EXP ISO
|
[Drinking Water deficiency co-treated with Furosemide co-treated with Iohexol] results in increased expression of NLRP3 protein [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of NLRP3 mRNA; [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of NLRP3 protein; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of NLRP3 mRNA]; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of NLRP3 protein]
|
CTD |
PMID:29860548 PMID:38705399 |
|
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,828,014...44,853,394
|
|
G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
multiple interactions
|
EXP
|
[Drinking Water deficiency co-treated with Furosemide co-treated with Iohexol] results in decreased expression of NQO1 mRNA
|
CTD |
PMID:29860548 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
G
|
Oas3
|
2'-5'-oligoadenylate synthetase 3
|
decreases expression
|
ISO
|
Iohexol results in decreased expression of OAS3 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr12:41,439,645...41,463,392
Ensembl chr12:41,439,643...41,464,420
|
|
G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
increases expression
|
ISO
|
Iohexol results in increased expression of PPARG mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
G
|
Ppif
|
peptidylprolyl isomerase F
|
multiple interactions increases expression
|
EXP ISO
|
Amlodipine inhibits the reaction [Iohexol results in increased expression of PPIF protein]; cilnidipine inhibits the reaction [Iohexol results in increased expression of PPIF protein]; Nifedipine inhibits the reaction [Iohexol results in increased expression of PPIF protein] Amlodipine inhibits the reaction [Iohexol results in increased expression of PPIF protein]; CAMK2G protein inhibits the reaction [Iohexol results in increased expression of PPIF protein]; cilnidipine inhibits the reaction [Iohexol results in increased expression of PPIF protein]; Nifedipine inhibits the reaction [Iohexol results in increased expression of PPIF protein]
|
CTD |
PMID:36207783 |
|
NCBI chr16:1,264,001...1,270,722
Ensembl chr16:1,263,541...1,316,954
|
|
G
|
Pycard
|
PYD and CARD domain containing
|
multiple interactions
|
ISO
|
[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of PYCARD mRNA; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of PYCARD mRNA]
|
CTD |
PMID:38705399 |
|
NCBI chr 1:192,032,124...192,033,419
Ensembl chr 1:192,032,124...192,033,419
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
increases expression
|
ISO
|
Iohexol results in increased expression of RELA mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
G
|
Rsad2
|
radical S-adenosyl methionine domain containing 2
|
decreases expression
|
ISO
|
Iohexol results in decreased expression of RSAD2 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 6:48,774,985...48,788,245
Ensembl chr 6:48,774,985...48,788,320
|
|
G
|
S100a4
|
S100 calcium-binding protein A4
|
increases expression
|
ISO
|
Iohexol results in increased expression of S100A4 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 2:178,388,529...178,390,838
Ensembl chr 2:178,388,526...178,390,837
|
|
G
|
Sox9
|
SRY-box transcription factor 9
|
increases expression
|
ISO
|
Iohexol results in increased expression of SOX9 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr10:98,305,744...98,311,250
Ensembl chr10:98,305,744...98,311,250
|
|
G
|
Sqstm1
|
sequestosome 1
|
multiple interactions
|
EXP ISO
|
Iohexol inhibits the reaction [[Drinking Water deficiency co-treated with Furosemide] results in increased expression of SQSTM1 protein] [Berberine co-treated with Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of SQSTM1 protein
|
CTD |
PMID:29860548 PMID:38705399 |
|
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750
|
|
G
|
Tgfb1
|
transforming growth factor, beta 1
|
multiple interactions
|
EXP
|
Carnitine inhibits the reaction [Iohexol promotes the reaction [Glycerol results in increased expression of TGFB1 mRNA]]; Iohexol promotes the reaction [Glycerol results in increased expression of TGFB1 mRNA]
|
CTD |
PMID:26562095 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
G
|
Thy1
|
Thy-1 cell surface antigen
|
decreases expression
|
ISO
|
Iohexol results in decreased expression of THY1 protein
|
CTD |
PMID:29705293 |
|
NCBI chr 8:53,286,396...53,291,541
Ensembl chr 8:53,286,148...53,291,540
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions increases expression
|
EXP ISO
|
Carnitine inhibits the reaction [Iohexol promotes the reaction [Glycerol results in increased expression of TNF mRNA]]; Carnitine inhibits the reaction [Iohexol promotes the reaction [Glycerol results in increased expression of TNF protein]]; Iohexol promotes the reaction [Glycerol results in increased expression of TNF mRNA]; Iohexol promotes the reaction [Glycerol results in increased expression of TNF protein] [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of TNF mRNA; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of TNF mRNA] Iohexol results in increased expression of TNF protein
|
CTD |
PMID:26562095 PMID:34774977 PMID:38705399 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
G
|
Tp53
|
tumor protein p53
|
increases expression
|
ISO
|
Iohexol results in increased expression of TP53 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
G
|
Tubb3
|
tubulin, beta 3 class III
|
increases expression
|
ISO
|
Iohexol results in increased expression of TUBB3 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr19:68,365,687...68,374,741
Ensembl chr19:68,365,587...68,374,740
|
|
G
|
Usp18
|
ubiquitin specific peptidase 18
|
decreases expression
|
ISO
|
Iohexol results in decreased expression of USP18 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 4:156,143,770...156,171,292
Ensembl chr 4:156,143,815...156,171,292
|
|
|
G
|
Gsta1
|
glutathione S-transferase alpha 1
|
multiple interactions
|
EXP
|
[Streptozocin co-treated with iomeprol] results in increased expression of GSTA1 protein; palmidrol analog inhibits the reaction [[Streptozocin co-treated with iomeprol] results in increased expression of GSTA1 protein]
|
CTD |
PMID:26474837 |
|
NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:31,199,888...31,211,528
|
|
G
|
Lcn2
|
lipocalin 2
|
multiple interactions
|
EXP
|
[Streptozocin co-treated with iomeprol] results in increased expression of LCN2 protein; palmidrol analog inhibits the reaction [[Streptozocin co-treated with iomeprol] results in increased expression of LCN2 protein]
|
CTD |
PMID:26474837 |
|
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842
|
|
G
|
Mapk8
|
mitogen-activated protein kinase 8
|
increases phosphorylation
|
ISO
|
iomeprol results in increased phosphorylation of MAPK8 protein
|
CTD |
PMID:21036957 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
G
|
Mapk9
|
mitogen-activated protein kinase 9
|
increases phosphorylation
|
ISO
|
iomeprol results in increased phosphorylation of MAPK9 protein
|
CTD |
PMID:21036957 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
|
|
G
|
Pim1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
affects expression
|
ISO
|
iomeprol affects the expression of PIM1 protein
|
CTD |
PMID:21036957 |
|
NCBI chr20:7,556,496...7,560,747
Ensembl chr20:7,556,113...7,561,764
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
increases phosphorylation
|
ISO
|
iomeprol results in increased phosphorylation of RELA protein
|
CTD |
PMID:21036957 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
G
|
Stat3
|
signal transducer and activator of transcription 3
|
affects expression
|
ISO
|
iomeprol affects the expression of STAT3 protein modified form
|
CTD |
PMID:21036957 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
|
G
|
Bak1
|
BCL2-antagonist/killer 1
|
increases expression
|
ISO
|
Iopamidol results in increased expression of BAK1 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,102,335...5,110,974
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases expression
|
ISO
|
Iopamidol results in increased expression of BAX mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
G
|
Bbc3
|
Bcl-2 binding component 3
|
increases expression
|
ISO
|
Iopamidol results in increased expression of BBC3 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:86,141,603...86,150,666
|
|
G
|
Casp9
|
caspase 9
|
multiple interactions increases expression
|
ISO
|
Iopamidol results in increased expression of and results in increased cleavage of CASP9 protein Iopamidol results in increased expression of CASP9 mRNA
|
CTD |
PMID:29705293 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
G
|
Cryab
|
crystallin, alpha B
|
increases expression
|
ISO
|
Iopamidol results in increased expression of CRYAB mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:59,989,814...59,995,528
|
|
G
|
Eng
|
endoglin
|
decreases expression
|
ISO
|
Iopamidol results in decreased expression of ENG protein
|
CTD |
PMID:29705293 |
|
NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:36,326,202...36,370,933
|
|
G
|
Fabp3
|
fatty acid binding protein 3
|
increases expression
|
ISO
|
Iopamidol results in increased expression of FABP3 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:147,936,119...147,942,881
|
|
G
|
Fabp4
|
fatty acid binding protein 4
|
increases expression
|
ISO
|
Iopamidol results in increased expression of FABP4 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972
|
|
G
|
Ifi44
|
interferon-induced protein 44
|
decreases expression
|
ISO
|
Iopamidol results in decreased expression of IFI44 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 2:243,286,050...243,303,869
Ensembl chr 2:243,286,052...243,306,877
|
|
G
|
Ifih1
|
interferon induced with helicase C domain 1
|
decreases expression
|
ISO
|
Iopamidol results in decreased expression of IFIH1 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 3:67,635,924...67,683,968
Ensembl chr 3:67,637,545...67,683,968
|
|
G
|
Map3k1
|
mitogen-activated protein kinase kinase kinase 1
|
increases expression
|
ISO
|
Iopamidol results in increased expression of MAP3K1 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:45,081,889...45,149,897
|
|
G
|
Mapk14
|
mitogen activated protein kinase 14
|
increases expression
|
ISO
|
Iopamidol results in increased expression of MAPK14 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
|
|
G
|
Mx1
|
MX dynamin like GTPase 1
|
decreases expression
|
ISO
|
Iopamidol results in decreased expression of MX1 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr11:50,269,056...50,294,699
Ensembl chr11:50,269,057...50,292,904
|
|
G
|
Oas3
|
2'-5'-oligoadenylate synthetase 3
|
decreases expression
|
ISO
|
Iopamidol results in decreased expression of OAS3 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr12:41,439,645...41,463,392
Ensembl chr12:41,439,643...41,464,420
|
|
G
|
Pmaip1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
increases expression
|
ISO
|
Iopamidol results in increased expression of PMAIP1 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
increases expression
|
ISO
|
Iopamidol results in increased expression of RELA mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
G
|
Rsad2
|
radical S-adenosyl methionine domain containing 2
|
decreases expression
|
ISO
|
Iopamidol results in decreased expression of RSAD2 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 6:48,774,985...48,788,245
Ensembl chr 6:48,774,985...48,788,320
|
|
G
|
S100a4
|
S100 calcium-binding protein A4
|
increases expression
|
ISO
|
Iopamidol results in increased expression of S100A4 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 2:178,388,529...178,390,838
Ensembl chr 2:178,388,526...178,390,837
|
|
G
|
Sox9
|
SRY-box transcription factor 9
|
increases expression
|
ISO
|
Iopamidol results in increased expression of SOX9 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr10:98,305,744...98,311,250
Ensembl chr10:98,305,744...98,311,250
|
|
G
|
Stat1
|
signal transducer and activator of transcription 1
|
decreases expression
|
ISO
|
Iopamidol results in decreased expression of STAT1 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:56,911,523...57,077,346
|
|
G
|
Thy1
|
Thy-1 cell surface antigen
|
decreases expression
|
ISO
|
Iopamidol results in decreased expression of THY1 protein
|
CTD |
PMID:29705293 |
|
NCBI chr 8:53,286,396...53,291,541
Ensembl chr 8:53,286,148...53,291,540
|
|
G
|
Tp53
|
tumor protein p53
|
increases expression
|
ISO
|
Iopamidol results in increased expression of TP53 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
G
|
Tubb3
|
tubulin, beta 3 class III
|
increases expression
|
ISO
|
Iopamidol results in increased expression of TUBB3 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr19:68,365,687...68,374,741
Ensembl chr19:68,365,587...68,374,740
|
|
G
|
Usp18
|
ubiquitin specific peptidase 18
|
decreases expression
|
ISO
|
Iopamidol results in decreased expression of USP18 mRNA
|
CTD |
PMID:29705293 |
|
NCBI chr 4:156,143,770...156,171,292
Ensembl chr 4:156,143,815...156,171,292
|
|
|
G
|
Edn1
|
endothelin 1
|
increases expression
|
EXP
|
iopromide results in increased expression of EDN1 protein
|
CTD |
PMID:21354280 |
|
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
|
|
G
|
Hexb
|
hexosaminidase subunit beta
|
increases secretion
|
ISO
|
iopromide results in increased secretion of HEXB protein
|
CTD |
PMID:34774977 |
|
NCBI chr 2:30,218,608...30,238,771
Ensembl chr 2:30,218,608...30,238,771
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
decreases phosphorylation
|
ISO
|
iopromide results in decreased phosphorylation of MAPK1 protein
|
CTD |
PMID:34774977 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
decreases phosphorylation
|
ISO
|
iopromide results in decreased phosphorylation of MAPK3 protein
|
CTD |
PMID:34774977 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
G
|
Mr1
|
major histocompatibility complex, class I-related
|
affects expression
|
ISO
|
iopromide affects the expression of MR1 mRNA
|
CTD |
PMID:25811541 |
|
NCBI chr13:69,850,420...69,868,302
Ensembl chr13:69,850,420...69,868,502
|
|
G
|
Nos2
|
nitric oxide synthase 2
|
decreases expression
|
EXP
|
iopromide results in decreased expression of NOS2 protein
|
CTD |
PMID:21354280 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
G
|
RT1-Da
|
RT1 class II, locus Da
|
affects expression
|
ISO
|
iopromide affects the expression of HLA-DRA mRNA
|
CTD |
PMID:25811541 |
|
NCBI chr20:4,515,393...4,520,387
Ensembl chr20:4,513,908...4,520,383
|
|
|
G
|
F2
|
coagulation factor II, thrombin
|
multiple interactions
|
ISO
|
Ioxaglic Acid inhibits the reaction [F2 protein binds to SERPINC1 protein]
|
CTD |
PMID:2020943 |
|
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:98,051,960...98,065,246
|
|
G
|
Serpinc1
|
serpin family C member 1
|
multiple interactions
|
ISO
|
Ioxaglic Acid inhibits the reaction [F2 protein binds to SERPINC1 protein]
|
CTD |
PMID:2020943 |
|
NCBI chr13:75,790,558...75,804,826
Ensembl chr13:75,790,546...75,817,643
|
|